ArticleOncotarget2015

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model.

Md Nabiul Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.